-
Part 3 | Session 2 2 Trials That Will Change My Practice with Dr Sahil Parikh
-
Part 1 | Session 1 View from the Thoraxcenter: TCT 24 Late-breaking Preview
-
Part 1 | Session 2 View from the Thoraxcenter: TCT 24 Late-breaking Science Wrap Up
-
Part 2 | Session 4 MATTERHORN: Transcatheter Repair Versus Surgery in Mitral Regurgitation
-
Part 2 | Session 5 INFINITY-SWEDEHEART: DynamX Bioadaptor in Patients with Complex Lesions
TCT Conference 2024 - In this highlights video from TCT 2024, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr. Alasnag discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in the field of interventional cardiology.
Trials covered in detail include:
EARLY-TAVR (00:33 - 01:31)
EVOLVED (01:31 - 02:31)
TAVR-UNLOAD (02:31 - 03:32)
ECLIPSE (03:31 - 05:53)
COSMIC-AS (05:53 - 06:24)
Recorded onsite at TCT 2024, Washington.
Support: This is an independent interview produced by Radcliffe Cardiology.
Keep informed with our video collection unveiling data from the Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.
- For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
- Our short Expert Interviews with select faculty offer focused data analysis and take-home messages for practice.
- To delve deeper into insights on the most pertinent trials, catch our Highlights.
Dive into the latest cardiology research with our upcoming TCT Conference coverage.
More from this programme
Part 1
View From the Thoraxcenter: What's Hot at TCT 24?
Part 2
Expert Interviews
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.
Academic History
Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…
Comments